Proteostasis Therapeutics Inc (NASDAQ:PTI)

3.05
Delayed Data
As of Jun 20
 -0.01 / -0.33%
Today’s Change
1.41
Today|||52-Week Range
8.61
-47.68%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$192.0M

Company Description

Proteostasis Therapeutics, Inc. engages in the research, development, and market of pharmaceutical products. Its medicines intend to treat cystic fibrosis, protein conformational and neurodegenerative diseases. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA.

Contact Information

Proteostasis Therapeutics, Inc.
80 Guest Street
Boston Massachusetts 02135
P:(617) 225-0096
Investor Relations:

Employees

Shareholders

Individual stakeholders53.58%
Other institutional37.94%
Mutual fund holders12.74%

Top Executives

Meenu Chhabra KarsonPresident, Chief Executive Officer & Director
Marija ZecevicChief Operating Officer
Helen M. BoudreauTreasurer, Chief Financial & Accounting Officer
Benito MunozChief Scientific Officer
Po-Shun LeeChief Medical Officer & Executive Vice President